Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease"

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)E59-E59
JournalInflammatory Bowel Diseases
Volume25
Issue number5
DOIs
Publication statusPublished - 2019

Cite this